The Canadian government announced that it would invest $25 million in a new biomanufacturing facility in Montreal, producing mRNA vaccines and other biologic drugs. The facility will be operated by biotech company AbCellera and is expected to create over 200 jobs in the region.
Shinpharma Inc. Canada.